These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 5810972)

  • 41. Decreased 17-hydroxycorticosteroid and VMA excretion during sleep following glutethimide administration in man.
    Rubin RT; Kales A; Clark BR
    Life Sci; 1969 Sep; 8(17):959-64. PubMed ID: 4309159
    [No Abstract]   [Full Text] [Related]  

  • 42. [Urinary elimination of VMA in acetate poisoning].
    Mascia D; Querci V
    Boll Soc Ital Biol Sper; 1969 May; 45(10):695-7. PubMed ID: 5399988
    [No Abstract]   [Full Text] [Related]  

  • 43. [Urinary excretion of catecholamines and 3-methoxy-4 hydroxy-mandelic acid in chronic schizophrenic patients undergoing Triperidol treatment].
    Masiak M; Zawiślak H
    Psychiatr Pol; 1973; 7(6):637-43. PubMed ID: 4773051
    [No Abstract]   [Full Text] [Related]  

  • 44. IV. Estimation by gas chromatography of urinary homovanillic acid and vanilmandelic acid in neuroblastoma.
    Williams CM; Greer M
    Methods Med Res; 1970; 12():106-14. PubMed ID: 5432487
    [No Abstract]   [Full Text] [Related]  

  • 45. [Study of urinary 3-methoxy-4 hydroxy-mandelic acid (VMA) in children. 1. Measurement of urinary VMA and its excretory rate in healthy children].
    Seki R
    Nihon Shonika Gakkai Zasshi; 1968 Nov; 72(11):1935-8. PubMed ID: 5753011
    [No Abstract]   [Full Text] [Related]  

  • 46. [The importance of the determination of urinary catecholamines and urinary vanilmandelic acid in the diagnosis and control of neuroblastoma therapy].
    Rutiloni C; Serra GB
    Minerva Pediatr; 1968 Dec; 20(48):2481-7. PubMed ID: 5715834
    [No Abstract]   [Full Text] [Related]  

  • 47. Urinary catecholamine metabolite concentrations in tetanus.
    Toothill C; Dykes JR; Ablett JJ
    Br J Anaesth; 1970 Jun; 42(6):524-30. PubMed ID: 5423842
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical significance of urinary VMA determination in the neuroblastoma].
    Hanawa Y; Ise Y; Murakami T; Sakauchi N; Nagato T
    Nihon Shonika Gakkai Zasshi; 1970 Feb; 74(2):252-9. PubMed ID: 5461857
    [No Abstract]   [Full Text] [Related]  

  • 49. Increased urinary excretion of catecholamines and their metabolites in streptozotocin diabetic rat.
    Kaul CL; Grewal RS
    Pharmacology; 1980; 21(3):223-8. PubMed ID: 7413723
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Determination of urinary 3-methoxy-4-hydroxymandelic acid (vanilmandelic acid) by electrophoresis with gelatinized cellulose acetate].
    Otsuji S; Kamisage T; Maeda S
    Igaku To Seibutsugaku; 1968 Oct; 77(4):111-6. PubMed ID: 5751541
    [No Abstract]   [Full Text] [Related]  

  • 51. [Laboratory indices of the activity of the sympatho-adrenal system in healthy persons].
    Bol'shakova TD; Gugutishvili TsG; Zutler AS; Kiseleva ZM; Kolesov DV
    Lab Delo; 1969; 6():323-6. PubMed ID: 4185828
    [No Abstract]   [Full Text] [Related]  

  • 52. [Urinary elimination of 5-hydroxy-indolacetic acid (5HIAA) and 3-methoxy-4-hydroxy-mandelic acid (VMA) during spontaneous and surgical menopause in relation to the incidence of vasomotor disorders].
    Gasparri F; Periti P; Lo Stumbo F
    Boll Soc Ital Biol Sper; 1966 Aug; 42(15):951-3. PubMed ID: 5969312
    [No Abstract]   [Full Text] [Related]  

  • 53. The excretion of 3-methoxy-4-hydroxy mandelic acid (VMA) by cattle skin.
    Mabon RM; Jenkinson DM
    Res Vet Sci; 1971 May; 12(3):289-92. PubMed ID: 5575485
    [No Abstract]   [Full Text] [Related]  

  • 54. Vanilmandelicaciduria in the different clinical phases of manic depressive psychosis.
    Campanini T; Catalano A; De Risio C; Mardighian G
    Br J Psychiatry; 1970 Apr; 116(533):435-6. PubMed ID: 5441802
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of furosemide on urinary excretion of 4-hydroxy-3-methoxymandelic acid (VMA).
    Bursztyn M; Gutman A
    Isr J Med Sci; 1985 Sep; 21(9):742-4. PubMed ID: 4055336
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical evaluation of a screening test for 3-methoxy-4-hydroxy mandelic acid (VMA).
    Stiles D; Batsakis JG; Cronkleton J; Czelada G
    Am J Med Technol; 1968 Apr; 34(4):205-10. PubMed ID: 5640833
    [No Abstract]   [Full Text] [Related]  

  • 57. [Changes in urinary catecholamines and vanilmandelic acid under the influence of insulin in patients with hyperestrogenism].
    Pencea V; Gneazdovschi V; Zbranca TE; Teodorescu E
    Rev Med Chir Soc Med Nat Iasi; 1970; 74(3):591-6. PubMed ID: 5474394
    [No Abstract]   [Full Text] [Related]  

  • 58. A seasonal change in the diurnal rhythm of the excretion of 3-methoxy-4-hydroxymandelic acid in man.
    Davies TW
    Q J Exp Physiol Cogn Med Sci; 1970 Apr; 55(2):122-8. PubMed ID: 5198733
    [No Abstract]   [Full Text] [Related]  

  • 59. Vanillyl mandelic acid excretion following open-heart surgery.
    Siggers DC; Fluck DC
    Guys Hosp Rep; 1970; 119(3):235-42. PubMed ID: 5491306
    [No Abstract]   [Full Text] [Related]  

  • 60. The effect of chronic reserpine administrated on vanilmandelic acid excretion, blood pressure and pulse rate in normal men.
    Davidson MB; Mager M; Killian P; Freinkel N
    Am J Med Sci; 1970 Jun; 259(6):405-11. PubMed ID: 5422284
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.